The QSAR model were successfully developed to calculate biological activity of 3, 5 di-substituted Pyrazoline derivatives as anticancer agents against AsPC-1 human pancreatic cell line and U251 human glioblastoma cell line, a good correlation models were obtained with R 2 =74.30% and R
Adam, N (2021). Modeling QSAR, Docking and Grinding Preparation of Some 3.5 Pyrazoline Derivatives, Against AsPC-1 Human Pancreatic Cell Line and U251 Human Glioblastoma Cell Line. Afribary. Retrieved from https://track.afribary.com/works/modeling-qsar-docking-and-grinding-preparation-of-some-3-5-pyrazoline-derivatives-against-aspc-1-human-pancreatic-cell-line-and-u251-human-glioblastoma-cell-line
Adam, Nihad "Modeling QSAR, Docking and Grinding Preparation of Some 3.5 Pyrazoline Derivatives, Against AsPC-1 Human Pancreatic Cell Line and U251 Human Glioblastoma Cell Line" Afribary. Afribary, 12 May. 2021, https://track.afribary.com/works/modeling-qsar-docking-and-grinding-preparation-of-some-3-5-pyrazoline-derivatives-against-aspc-1-human-pancreatic-cell-line-and-u251-human-glioblastoma-cell-line. Accessed 27 Sep. 2024.
Adam, Nihad . "Modeling QSAR, Docking and Grinding Preparation of Some 3.5 Pyrazoline Derivatives, Against AsPC-1 Human Pancreatic Cell Line and U251 Human Glioblastoma Cell Line". Afribary, Afribary, 12 May. 2021. Web. 27 Sep. 2024. < https://track.afribary.com/works/modeling-qsar-docking-and-grinding-preparation-of-some-3-5-pyrazoline-derivatives-against-aspc-1-human-pancreatic-cell-line-and-u251-human-glioblastoma-cell-line >.
Adam, Nihad . "Modeling QSAR, Docking and Grinding Preparation of Some 3.5 Pyrazoline Derivatives, Against AsPC-1 Human Pancreatic Cell Line and U251 Human Glioblastoma Cell Line" Afribary (2021). Accessed September 27, 2024. https://track.afribary.com/works/modeling-qsar-docking-and-grinding-preparation-of-some-3-5-pyrazoline-derivatives-against-aspc-1-human-pancreatic-cell-line-and-u251-human-glioblastoma-cell-line